Abstract:Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA Enhanced Src activation has been implicated in many cancers, including those of breast, lung and pancreas. However single-agent therapies targeting Src have achieved limited success in the clinical setting. It remains unclear what regulatory influence Src has at the kinomic level, where many anti-cancer drug targets are found. This study aims to define the Src-regulated kinome by using a cutting-edge chemical proteomics strategy, and to combine this with functional genomics in order to identify kinase signaling networks that are important for Src-induced oncogenesis. This may ultimately identify potential therapeutic strategies for cancers with aberrant Src activity, that involve, for example, targeting Src in combination with a downstream kinase. We first developed a novel kinase capture reagent termed CTx-0294885 for kinase enrichment. This allows the identification of more than 230 protein kinases at the level of protein expression and phosphorylation by mass spectrometry. The combination of CTx-0294885 with 3 other existing kinase capture reagents led to the greatest kinome coverage in a single cell line reported to date (Zhang 2013). We then applied this kinase enrichment technique in combination with quantitative mass spectrometry to identify the Src-regulated kinome. This was achieved by comparing global kinase activation profiles in control MCF-10A immortalized mammary epithelial cells and MCF-10A cells expressing constitutively active Src. Nearly 300 protein kinases and 1500 kinase-derived phosphosites were identified from the kinome profiling. Importantly, over 100 kinases respond to Src activation with changes at the protein expression or phosphorylation level. This Src-regulated kinome contains: several well characterized kinases that are already being targeted in the clinical setting, such as Egfr and Braf; proto-oncogenes implicated in breast cancer but with no current functional link to Src, such as Ikke; kinases involved in tumor suppression such as Lats1/2 and the Tao family kinases; and many poorly characterized kinases that may represent novel targets for drug discovery. In addition, approximately 70 other proteins co-purified with protein kinases also exhibited changes upon Src activation. These include several lipid kinases and numerous proteins involved in RNA metabolism. All of these Src-regulated proteins are currently being functionally characterized by a focused RNAi screen, specifically regarding their roles in cell viability, migration and morphology. This study will provide novel insights into the global impact of Src-induced transformation on the expressed kinome and may lead to identification of novel therapeutic targets and combination treatment strategies. Reference: Zhang L, Daly R.J et al. 2013. Characterization of a novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling. J Proteome Res. 2013 Jul 5;12(7):3104-16. Citation Format: Luxi Zhang, Jianmin Wu, Roger J. Daly. Characterization of the Src-regulated kinome by chemical proteomics. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 1613. doi:10.1158/1538-7445.AM2014-1613

Lipid-driven SRC self-association modulates its transformation capacity

Binding-induced lipid domains: Peptide-membrane interactions with PIP2 and PS

Lipids Regulate Lck Protein Activity Through Their Interactions with the Lck Src Homology 2 Domain

The conformation of the nSrc specificity-determining loops in the Src and Abl SH3 domains are modulated by a WX conserved sequence motif

The conformation of the nSrc specificity-determining loop in the Src SH3 domain is modulated by a WX conserved sequence motif found in SH3 domains

Anatomy of a structural pathway for activation of the catalytic domain of Src kinase Hck

Mechanisms controlling membrane recruitment and activation of autoinhibited SHIP1

Insights into Membrane Association of the SMP Domain of Extended Synaptotagmin.

Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase

The Src SH2 domain interacts dynamically with the focal adhesion kinase binding site as demonstrated by paramagnetic nmr spectroscopy

SH2 Domains Serve as Lipid-Binding Modules for pTyr-Signaling Proteins.

Molecular conformation dictates signaling module formation: example of PKCepsilon and Src tyrosine kinase.

Molecular conformation dictates signaling module formation: example of PKCε and Src tyrosine kinase

Src kinase slows collective rotation of confined epithelial cell monolayers

Visualization Of Src Activity At Different Compartments Of The Plasma Membrane By Fret Imaging

Two Amino Acid Residues Confer Different Binding Affinities of Abelson Family Kinase SRC Homology 2 Domains for Phosphorylated Cortactin.

Ca2+/Calmodulin and Apo-Calmodulin Both Bind to and Enhance the Tyrosine Kinase Activity of c-Src

Tyrosine 192 within the SH2 domain of the Src-protein tyrosine kinase p56Lck regulates T-cell activation independently of Lck/CD45 interactions

Lipidation alters the phase-separation of resilin-like polypeptides

Characterization Of The Src-Regulated Kinome By Chemical Proteomics